Cargando…
Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
The therapeutic sc"enario of metastatic renal cell cancer (mRCC) has noticeably increased, ranging from the most studied molecular target therapies to those most recently introduced, up to immune checkpoint inhibitors (ICIs). The most recent clinical trials with an ICI-based combination of mole...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100507/ https://www.ncbi.nlm.nih.gov/pubmed/33968762 http://dx.doi.org/10.3389/fonc.2021.657639 |